Data Curation and Entry in DIDB – March Summary

In March, we added 104 citations in DIDB, including 37 in vitro (with 11 articles published in Mar. 2022) and 67 in vivo articles (with 19 articles published in Mar. 2022).

Four recently approved NDAs/BLAs were also added with the following 1 NDA: daridorexant (QUVIVIQ), and the following 3 BLAs: faricimab (VABYSMO), sutimlimab (ENJAYMO), tebentafusp (KIMMTRAK).

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.